We strive to be the worldwide reference provider of organs preservation technologies. Our work is inspired by our commitment to consistently meeting customer and regulatory requirements, to delivering quality products and to providing an innovative and comprehensive offer for organ preservation.
Institut Georges Lopez, more often referred to as IGL, consists of a network of subsidiaries located worldwide. This means we are never far from our customers and so can help them to meet their local challenges.
We design, manufacture, and market proprietary and generic products for organ preservation classified as drugs or medical devices. Our products are essential for the success of organ transplantations.
IGL is wholly owned by GROUPE CAIR.
Georges Antoine Lopez
President
Daniel Humbert
Chief Executive Officer
Delphine Molinari
Quality & Regulatory Affairs Director
Nathalie Tan
Pharm.D.
Head Pharmacist and Managing Director of IGL
Humberto Sobrinho
M.B.A.
Managing Director of IGL America Latina
Michael D. Christ
Chief Executive Officer of Waters Medical Systems
Marc Net
PhD
Research Director
Charles H. Patrick
MHA, CPTC, CTP
Manager, Clinical Support Services, Renal Perfusion
II.4 certificate
NF EN ISO13485 : 2012
ISO9001 : 2008
GMP certificate
